Keenan Greg
- SEC CIK
- 0002044006
No open-market purchases or sales filed in the past year.
Current role at each company
- AUPH Aurinia Pharmaceuticals Inc.SVP, Chief Medical Officeras of Mar 10, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Keenan Greg as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2025 (view filing) | Aug 1 | 4 days | Keenan GregChief Medical Officer | SSale | −20.0K | $10.50 | −$210.0K | −13.0%133.5K after | |
| Mar 7, 2025 (view filing) | Mar 7 | Same day | Keenan GregChief Medical Officer | SSale | −8.30K | $8.23 | −$68.4K | −5.1%153.5K after | |
| Mar 4, 2025 (view filing) | Mar 3 | 1 day | Keenan GregChief Medical Officer | SSale | −12.2K | $8.00 | −$97.9K | −7.0%161.8K after |